Morning Watch: Juno Therapeutics (JUNO), Puma Biotechnology (PBYI), Ignyta, Inc. (RXDX)

Juno Therapeutics Inc. (JUNO) is up $6.53, or 12.30%, at $59.75 following comments from AstraZeneca (AZN) CEO expressing interest in immuno-oncology companies. Seattle-based Juno, among the few companies developing a new class of immuno-oncology treatments called CAR-T cell therapies, has a current market cap of $5.42 billion. Puma Biotechnology, Inc. (PBYI) is under heavy pressure […] View the full post at: Morning Watch: Juno Therapeutics (JUNO), Puma Biotechnology (PBYI), Ignyta, Inc. (RXDX) Related posts: Morning Update: Market Thread Dec 1, 2009 Sunday Morning Coffee: Market Thoughts Morning Update: Market Thread Nov 20, 2009